Multiple myeloma (MM) is a spectrum of diseases that progresses from pre-malignant stages of monoclonal gammopathy of undetermined significance (MGUS), solitary plasmacytoma (SP), through smoldering multiple myeloma (SMM), to the malignant stages of clinical MM and plasma cell leukemia (PCL). The disease progression is associated with pathological molecular genetic events.